REFERENCES
L. Gu. Personal communication, Syntex Research.
A. Hussain, S. Hirai, and R. Bawarshi. Nasal absorption of propanolol in rats. J. Pharm. Sci. 68:1196 (1979).
A. Hussain, T. Foster, S. Hirai, T. Kashihara, R. Batenhorst, and M. Jones. Nasal absorption of propanolol in humans. J. Pharm. Sci. 69:1240 (1980).
A. Hussain, S. Hirai, and R. Bawarshi. Nasal absorption of propanolol from different dosage forms by rats and dogs. J. Pharm. Sci. 69:1411–1413 (1980).
G. F. X. David, C. P. Puri, and T. C. Anand Kumar. Bioavailability of progesterone enhanced by intranasal spraying. Experientia 37:533–534 (1981).
K. S. E. Su, K. M. Campanale, and C. L. Gries. Nasal drug delivery system of a quaternary ammonium compound: Clofilium tosylate. J. Pharm. Sci. 73:1251–1254 (1984).
K. S. E. Su, K. M. Campanale, L. G. Mendelsohn, G. A. Kerchner, and C. L. Gries. Nasal delivery of polypeptides. I. Nasal absorption of enkephalins in rats. J. Pharm. Sci. 74:394–398 (1985).
A. T. Wu, J. Thompson, and I. J. Massey. Specific determination of RS-93522 and its pyridine metabolite in plasma by HPLC method employing mixed mode separation. Pharm. Res. 3:5S (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cherng-Chi Fu, R., Whatley, J.L. & Fleitman, J.S. Intranasal Delivery of RS-93522, a Dihydropyridine-Type Calcium-Channel Antagonist. Pharm Res 8, 134–135 (1991). https://doi.org/10.1023/A:1015811230038
Issue Date:
DOI: https://doi.org/10.1023/A:1015811230038